Satellos Bioscience Inc
(MSCLF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,800 | -3,640 | -2,340 | -1,410 | -790 |
| Depreciation Amortization | 20 | 80 | 70 | 40 | 20 |
| Other Working Capital | 810 | 690 | 320 | 240 | 70 |
| Other Operating Activity | 410 | 110 | 90 | 90 | 100 |
| Operating Cash Flow | $-560 | $-2,760 | $-1,860 | $-1,040 | $-600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -3 | -3 | 0 | 660 |
| Other Investing Activity | 90 | 403 | 763 | 950 | 0 |
| Investing Cash Flow | $90 | $400 | $760 | $950 | $660 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 380 | 2,690 | 2,330 | 3 | 2 |
| Financing Cash Flow | $380 | $2,690 | $2,330 | $3 | $2 |
| Exchange Rate Effect | 3 | 3 | 0 | 0 | 0 |
| Beginning Cash Position | 590 | 250 | 250 | 250 | 250 |
| End Cash Position | 500 | 590 | 1,480 | 160 | 340 |
| Net Cash Flow | $-80 | $340 | $1,220 | $-90 | $90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -560 | -2,760 | -1,860 | -1,040 | -600 |
| Free Cash Flow | -560 | -2,760 | -1,860 | -1,040 | -600 |